Psychedelic syndrome

Psychedelic syndrome
Other namesChronic LSD syndrome; "Acid head" syndrome
SpecialtyPsychiatry
SymptomsEccentricity, magical and superstitious beliefs, isolation from general society, others
CausesChronic psychedelic use
TreatmentPsychotherapy

Psychedelic syndrome, also known as chronic LSD syndrome or "acid head" syndrome, is a partially culture-bound psychological syndrome that was proposed to involve pronounced psychosocial and personality changes due to chronic or prolonged use of psychedelic drugs, namely LSD.[1][2][3][4][5][6] It was first proposed in 1969 by a physician named David E. Smith, who was the founder and medical director of the Haight Ashbury Free Clinic (also known as the "hippie clinic") in the Haight-Ashbury district of San Francisco and who had encountered many people frequently using LSD.[1][3][4][5] He was also an academic and the founder and editor of the Journal of Psychedelic Drugs (1967–present).[5][7] Others besides Smith made similar or analogous informal observations of the phenomenon as well.[2][6]

According to Smith, the syndrome resulted in profound alterations in psychosocial functioning and lifestyle.[3][5][8][6] The symptoms of the syndrome were claimed to include belief in magic or magical concepts; intense study of "metaphysical objects"; superstition; belief in astrology; belief in mental telepathy, extrasensory perception (ESP), and telekinesis; mysticism; and isolation from general or mainstream society.[1][2][3][4][5][8][6] Additional symptoms were said to include a profound belief in non-violence and rejection of physical aggression, with consequent frequent adoption of vegetarianism due to the rejection of killing; a deep desire to return to nature and more natural ways of being; and self-psychoanalytic, pseudoreligious, and creative aspirations.[1][3][5][8][6][9] The symptoms were said to be uncharacteristic of the demographics of the individuals exhibiting them, for instance many of them being from middle-class homes, being above-average in intelligence, previously holding conventional beliefs, and having little background in mystical ideas.[4][5][6][9] They were also said to not be consistent with schizophrenia, as cognitive abilities and intense interpersonal relationships remained intact, and the individuals could only be described as "eccentric".[4][5][8][6][2] The syndrome and its symptoms have also been referred to as an "unstructured psychedelic religion".[1][4][5][8]

People who were claimed to have had psychedelic syndrome often belonged to the psychedelic community or hippie subculture and frequently grouped together in communal living situations.[2][3][4][5][8][6][9] They did not feel themselves to be mentally ill and were not considered sick by other members of their community.[3][4][5][8][6] As such, the syndrome could only be considered a psychological aberration in terms of the established standards of the dominant culture.[4][5][8][6][2] This was said to make "treatment" of the syndrome, such as psychotherapy, "virtually impossible", at least as long as the individuals continued to remain in their social groups.[4][5][8][6] Psychological stress and crisis prompted by events like parental, spousal, or monetary pressure were said to usually precipitate "re-entry attempts" into "straight" society.[4][5][6] Psychedelic syndrome was thought to be both due to the powerful effects of psychedelics as well as due to cultural influences.[2][4][5][8] Contemporary assessments of psychedelic syndrome have been made and have attributed the conceptualization of the syndrome to the social conservatism of the dominant culture at the time.[1][2] However, others have considered the syndrome with more credence and have noted that similar phenomena do not seem to occur with other psychoactive drugs.[10]

Subsequent scientific research has reported that psychedelics seem to foster development of alternative perspectives on reality and soften conceptual boundaries.[2][11] They have also since been found to produce lasting personality changes such as increased openness and self-transcendence,[12][13][14] cause changes in cognitive flexibility,[15][16] increase neuroplasticity,[17][18][19] and reopen developmental windows or critical learning periods.[17][20][21] In addition, psychedelics have been found to increase nature relatededness as well as pro-environmental behavior.[22][23][24][25][26][27][28] They have been found to increase the quantity and subjective intensity of insights and thus beliefs, including false ones, as well.[29][30] Development of psychosis or schizophrenia due to use of psychedelics appears to be rare and more specific to those with pre-existing susceptibility.[31][32][33][34][35][36] In addition, psychedelics might be able to treat certain symptoms of schizophrenia, like negative and depressive symptoms.[37][38][32][33][39][40]

A somewhat related concept to psychedelic syndrome is Josie Kins's concept of "McKenna syndrome", which she proposes involves overactivation of spiritual or religious drives due to abundant use of psychedelics and causes psychological changes including excessive big-picture thinking, theorizing about reality or the universe and one's place in it, and compulsively evangelizing one's grand cosmic theories to the exclusion of other content.[10]

See also

References

  1. 1 2 3 4 5 6 Majić T, Gouzoulis-Mayfrank E, Evens R (2026). "Classifying Psychedelic-Related Complications". Psychedelic Harm Reduction. Curr Top Behav Neurosci. Vol. 77. pp. 127–151. doi:10.1007/7854_2026_614. ISBN 978-3-032-21106-4. PMID 41749025. A physician working in the emergency room of a hospital in Haight-Ashbury, San Francisco, described personality changes in LSD users that he labeled "The Psychedelic Syndrome" (Smith 1969). These included the following aspects: "profound belief in non-violence including change in diet to vegetarian, natural food, and other natural things like natural childbirth, deep desire to return to nature, profound psychological conversion to a psychedelic religion, dress and customs of American Indians, and magical thinking." From a contemporary perspective, these characteristics appear far less pathological than they did in the 1960s, underscoring the importance of the sociocultural context in which symptoms are observed.
  2. 1 2 3 4 5 6 7 8 9 Mangini M (9 March 2021). "A Short, Strange Trip: LSD Politics, Publicity, and Mythology—from Discovery to Criminalization". In Grob CS, Grigsby J (eds.). Handbook of Medical Hallucinogens. Guilford Publications. pp. 68–94. ISBN 978-1-4625-4544-5. A "psychedelic syndrome" (D. Smith, 1969) of "dyssocial" (Cohen, 1966), unproductive (Carlin & Post, 1974), and alienated behavior (U.S. House of Representatives, 1968) was believed to afflict those who had become involved with the psychedelic drugs. Behaviors cited as evidence of this problem included rejection of Judeo-Christian roots for Eastern spirituality (Cole & Katz, 1964), political "passivism" (Schachter, 1968), adoption of patterns of magical and cosmic thinking (Smith, 1969), sexual license (Farnsworth & Weiss, 1969), and a preference for bizarre dress and inadequate personal hygiene (Bingham, 1967). The fearful question on the minds of spokespeople for the parental generation was whether these disaffiliated and deranged youngsters would ever be able to take up the responsibilities of adulthood and the reins of government, business and community responsibility in the future (Farnsworth, 1968; Robitscher, 1969; Watts, 1977; Wittenborn, 1969). Unusual beliefs and unpopular attitudes have frequently been "scientifically" diagnosed as psychiatric illness, spiritual malaise, and community affliction based on personal and cultural value judgments. [...] Psychedelic substances seem to facilitate the development of alternative perspectives on reality and soften conceptual boundaries (Cleckner, 1977). [...] Whether or not the repeat user experienced any immediate adverse psychedelic effects, the combination of multiple psychedelic experiences and membership, in some kind of "psychedelic community" or social world in which alternative beliefs, perceptions, and knowledge systems not based on sense data were attended to and validated, was thought to facilitate the development of the "psychedelic syndrome" (Smith, 1969). The clinical picture of those affected was one of discernible changes in beliefs and values despite intact cognitive abilities. [...]
  3. 1 2 3 4 5 6 7 Tochka, Nicholas (8 January 2026). The Musical Lives of Charles Manson: The Beatles, the Beach Boys, and the Invention of the Sixties—or, No Sense Makes Sense. Bloomsbury Publishing USA. ISBN 978-1-5013-8457-8. Retrieved 19 July 2026. A year later and writing on the opposite coast, Dr. David E. Smith reached different conclusions. "It is often said that young people who involve themselves in what can be called the psychedelic movement are going through a 'phase' and will become 'straight' again," Smith wrote in Clinical Pediatrics. But this might not be the case. Both heavy LSD users and individuals committed to "the psychedelic subculture," Smith claimed, show evidence of "profound alterations in psychosocial functioning," which he proposed to call "psychedelic syndrome." An essential incompatibility between the values of the psychedelic underground, emphasizing communalism and love, and those of the dominant straight culture, with its ethics of individual competition and violence, exacerbated the situation. "So long as they remain in the psychedelic subculture their psychedelic syndrome, with its characteristics of nonviolence and magical beliefs, is actually respected," Smith concluded. "They cannot be called mentally ill by the standards of their community-only by the standards of ours." And not only that, but get this: "Becoming straight [again] can cause severe psychologic[al] problems, and be a much more difficult process than most adults predict."67
  4. 1 2 3 4 5 6 7 8 9 10 11 12 Smith, David E. (1969). "LSD and the Psychedelic Syndrome". Clinical Toxicology. 2 (1): 69–73. doi:10.3109/15563656908990915. ISSN 0009-9309. Archived from the original on 19 July 2026.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Smith DE (February 1969). "Changing drug patterns in the Haight-Ashbury". Calif Med. 110 (2): 151–157. PMC 1503277. PMID 5784117.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 Smith, David E. (1970). "LSD, Violence and Radical Religious Beliefs". Journal of Psychedelic Drugs. 3 (1): 38–40. doi:10.1080/02791072.1970.10471360. ISSN 0022-393X. Retrieved 19 July 2026.
  7. ↑ https://personal.drdave.org/David-E-Smith-MD-FASAM-FAACT-CV-updated-2015-03-415-566-1259.pdf
  8. 1 2 3 4 5 6 7 8 9 10 Smith DE (April 1969). "Speed freaks vs. acid heads. Conflict between drug subcultures". Clin Pediatr (Phila). 8 (4): 185–188. doi:10.1177/000992286900800401. PMID 5776448.
  9. 1 2 3 Smith DE, Sternfield J (April 1970). "The hippie communal movement: effects on child birth and development". Am J Orthopsychiatry. 40 (3): 527–530. doi:10.1111/j.1939-0025.1970.tb00711.x. PMID 5422301. Within the past few years a significant new element has appeared in America's communal movement as thousands of alienated young people from predominantly middle-class backgrounds have found this alternative life style increasingly attractive. Hundreds of hippie communes have appeared in the United States, particularly in California and Oregon. Common to most seems to be a belief system of mysticism and nonviolence derived primarily from the use of psychedelic drugs, with LSD and marijuana maintaining premier positions.3,4,6
  10. 1 2 Haley Maria Dourron (3 July 2026). "Lexicons of the Ineffable: A Conversation with Josie Kins, PsychonautWiki Founder" (Podcast). Furthure. Josie Kins (interviewee). [Dourron:] I mean, one thing we've brought up briefly already, but I was really kind of like a fan of how you described this phenomenon because I've been curious with about it for a while, is the concept of McKenna Syndrome. Do you want to describe what that is? [...] [Kins:] First of all, Terence McKenna is my childhood hero and I love the guy, but he did have a serious case in McKenna syndrome. And I would say that pretty much anyone that's done a lot of psychedelics or knows people that have taken a lot of psychedelics will understand what I mean here. But if you do a lot of psychedelics, eventually what I assume is some sort of religious or spirituality framework drive that seems to just exist within the human mind gets over activated and people will start to construct bigger picture context or theories of reality or the universe of their life that they fit themselves into. As far as I can tell, spirituality is largely about putting your life into a bigger picture context as a way to derive meaning. I suspect it's a natural thing that humans do. It's not just cultural. I think we have some sort of biological or neurological drive to do this, and psychedelics will activate this drive and they can over activate it. [...] at high levels, people will start just compulsively evangelizing their grand cosmic theories and they will have trouble talking about anything else. [...] But pretty much anyone who has taken a lot of psychedelics understand it. [...] [Dourron:] Yeah, I, I've read some older literature from like the 1960s that describes a similar phenomena as psychedelic syndrome, basically people becoming in these early papers, like obsessed with religion and psychedelic culture and trying to basically convert people, you know, turn on the world, all of that. It's interesting. And I don't quite see it with other classes of substances, which is why it's so odd to me. [...]
  11. ↑ Cleckner, Patricia J. (1977). "Hallucinogens in the United States: A Diagnostic Evaluation". Journal of Psychedelic Drugs. 9 (2): 133–141. doi:10.1080/02791072.1977.10472039. ISSN 0022-393X. Psychotropic drugs and ecstatic states are often incorporated into rituals and used by groups which are in some way outside the ongoing social structure. It appears that hallucinogenic substances have the property of melting conceptual boundaries and facilitating alternate perspectives on reality. These are precisely the effects necessary for the resolution of ambiguity and initiation of new social roles and functions.
  12. ↑ Knudsen GM (January 2023). "Sustained effects of single doses of classical psychedelics in humans". Neuropsychopharmacology. 48 (1): 145–150. doi:10.1038/s41386-022-01361-x. PMC 9700827. PMID 35729252.
  13. ↑ Bouso JC, Dos Santos RG, Alcázar-Córcoles MÁ, Hallak JE (April 2018). "Serotonergic psychedelics and personality: A systematic review of contemporary research". Neurosci Biobehav Rev. 87: 118–132. doi:10.1016/j.neubiorev.2018.02.004. PMID 29452127.
  14. ↑ Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JE, Dos Santos RG (May 2026). "Classic psychedelics and personality: An updated systematic review". J Psychopharmacol. 40 (8) 02698811261449386. doi:10.1177/02698811261449386. PMID 42218644.
  15. ↑ Kosted R, Doss MK, Donegan JJ, Cisler JM, Fonzo GA (September 2026). "Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes". Neurosci Biobehav Rev. 188 106788. doi:10.1016/j.neubiorev.2026.106788. PMC 13331243. PMID 42219133.
  16. ↑ Yang A, Lv X, Wang H, Wang X (August 2025). "Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity". ACS Chem Neurosci. 16 (15): 2750–2752. doi:10.1021/acschemneuro.5c00509. PMID 40702747.
  17. 1 2 Siegel JS, Liston C, Nicol GE, Carhart-Harris RL, Bogenschutz MP (February 2026). "The science of psychedelic medicine". Nat Med. 32 (2): 449–462. doi:10.1038/s41591-025-04194-5. PMID 41652120.
  18. ↑ Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D (May 2025). "Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models". Neurosci Biobehav Rev. 172 106132. doi:10.1016/j.neubiorev.2025.106132. PMID 40185376.
  19. ↑ Calder AE, Hasler G (January 2023). "Towards an understanding of psychedelic-induced neuroplasticity". Neuropsychopharmacology. 48 (1): 104–112. doi:10.1038/s41386-022-01389-z. PMC 9700802. PMID 36123427.
  20. ↑ Caulfield A, Young AH, Mehta M (May 2026). "Learning as the unifying mechanism of psychedelic action". J Psychopharmacol. 40 (5): 678–686. doi:10.1177/02698811251405683. PMC 13310274. PMID 41451530.
  21. ↑ Radwan K (July 2026). "Reopening developmental windows: Social play, safety, autonomic flexibility, and the therapeutic potential of psychedelics". Neurosci Biobehav Rev. 186 106714. doi:10.1016/j.neubiorev.2026.106714. PMID 42044753.
  22. ↑ Janhonen J, Kähönen J, Salmi I (May 2026). "Nature Relatedness as an Orientation in Moral Psychology". Integr Psychol Behav Sci. 60 (2) 39. doi:10.1007/s12124-026-09996-x. PMC 13139279. PMID 42082818.
  23. ↑ Forstmann M, Sagioglou C (August 2017). "Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness". J Psychopharmacol. 31 (8): 975–988. doi:10.1177/0269881117714049. PMID 28631526.
  24. ↑ Lyons T, Carhart-Harris RL (July 2018). "Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression". J Psychopharmacol. 32 (7): 811–819. doi:10.1177/0269881117748902. PMC 6047302. PMID 29338538.
  25. ↑ Kettner H, Gandy S, Haijen EC, Carhart-Harris RL (December 2019). "From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner". Int J Environ Res Public Health. 16 (24): 5147. Bibcode:2019IJERP..16.5147K. doi:10.3390/ijerph16245147. PMC 6949937. PMID 31888300.
  26. ↑ Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R (2020). "The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health". Health Psychol Open. 7 (2) 2055102920978123. doi:10.1177/2055102920978123. PMC 7724423. PMID 33335742.
  27. ↑ Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D (January 2023). "Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness". J Psychopharmacol. 37 (1): 93–106. doi:10.1177/02698811221146356. PMC 9834326. PMID 36601974.
  28. ↑ Longo MS, Bienemann B, Multedo M, Negreiros MA, Schenberg E, Mograbi DC (2023). "The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness". J Psychoactive Drugs. 55 (4): 402–410. doi:10.1080/02791072.2022.2112788. PMID 35984245.
  29. ↑ Kugel J, Laukkonen RE, Yaden DB, Yücel M, Liknaitzky P (June 2025). "Insights on psychedelics: A systematic review of therapeutic effects". Neurosci Biobehav Rev. 173 106117. doi:10.1016/j.neubiorev.2025.106117. PMID 40127876.
  30. ↑ McGovern HT, Grimmer HJ, Doss MK, Hutchinson BT, Timmermann C, Lyon A, Corlett PR, Laukkonen RE (August 2024). "An Integrated theory of false insights and beliefs under psychedelics". Communications Psychology. 2 (1) 69. doi:10.1038/s44271-024-00120-6. PMC 11332244. PMID 39242747.
  31. ↑ Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M (March 2025). "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies". Mol Psychiatry. 30 (3): 1223–1255. doi:10.1038/s41380-024-02800-5. PMC 11835720. PMID 39592825.
  32. 1 2 Sapienza J, Martini F, Comai S, Cavallaro R, Spangaro M, De Gregorio D, Bosia M (February 2025). "Psychedelics and schizophrenia: a double-edged sword". Mol Psychiatry. 30 (2): 679–692. doi:10.1038/s41380-024-02743-x. PMID 39294303.
  33. 1 2 Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (July 2026). "The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential". J Psychopharmacol. 40 (7): 1037–1053. doi:10.1177/02698811261456191. PMC 13376330. PMID 42345450.
  34. ↑ Honk L, Stenfors CU, Goldberg SB, Hendricks PS, Osika W, Dourron HM, Lebedev A, Petrovic P, Simonsson O (April 2024). "Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom". J Affect Disord. 351: 194–201. doi:10.1016/j.jad.2024.01.197. PMC 10922895. PMID 38280572.
  35. ↑ Simonsson O, Goldberg SB, Osika W, Stenfors CU, Chaturvedi S, Swords CM, Narayanan J, Hendricks PS (March 2025). "Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms". Psychol Med. 55 e99. doi:10.1017/S0033291725000716. PMC 12094617. PMID 40162511.
  36. ↑ Dourron HM, Bradley M, Simonsson O, Copes H, Grossman D, Shallcross RA, Hendricks PS (June 2025). "Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders". Psychedelic Med (New Rochelle). 3 (2): 93–102. doi:10.1089/psymed.2024.0036. PMC 12169207. PMID 40530408.
  37. ↑ Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-Levy U, Lotan A, Lerer B (January 2023). "Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation". Mol Psychiatry. 28 (1): 44–58. doi:10.1038/s41380-022-01832-z. PMID 36280752.
  38. ↑ Maćkowiak M (December 2023). "Psychedelics action and schizophrenia". Pharmacol Rep. 75 (6): 1350–1361. doi:10.1007/s43440-023-00546-5. PMC 10661800. PMID 37899392.
  39. ↑ Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J (June 2026). "Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review". Schizophr Res. 292: 69–78. doi:10.1016/j.schres.2026.03.003. PMID 41830808.
  40. ↑ Dourron HM, Copes H, Grossman DH, Bradley M, Nicholas CR, Turner JA, Allen-Clark G, Gossage M, Hendricks PS (2025). "How do psychedelics impact people with a history of non-affective psychosis? A qualitative study". Front Psychiatry. 16 1716545. doi:10.3389/fpsyt.2025.1716545. PMC 12722819. PMID 41446307.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.